Getein Biotech

Getein Biotech, founded in 2002, operates as a prominent biotechnology firm specializing in the research, development, production, and distribution of in vitro diagnostic reagents and instruments. The company maintains a strong focus on point-of-care testing (POCT) solutions, providing comprehensive diagnostic tools to healthcare institutions across the globe. By leveraging advanced manufacturing processes, the firm supports clinical diagnostics in over 126 countries, establishing a robust international footprint within the medical technology sector.

With a workforce of 1,000-5,000 employees, Getein Biotech drives innovation through dedicated engineering and technical teams. Meet Getein Biotech's team to understand the organizational structure and the expertise behind their diagnostic advancements. The company collaborates with more than 30,000 partners, ensuring that their diagnostic instruments meet the rigorous demands of modern healthcare environments. This collaborative network facilitates the rapid deployment of testing solutions, enhancing clinical outcomes and operational efficiency for medical facilities worldwide.

As the first company in the POCT field listed on the main board of the Shanghai Stock Exchange, Getein Biotech demonstrates significant market leadership. The firm generates annual revenue of $201.1M, reflecting its sustained growth and commitment to the biotechnology industry. By focusing on high-precision test and measurement equipment, the company continues to advance human health through scalable diagnostic technologies. Their strategic focus remains on integrating innovative biotech solutions into global healthcare systems, ensuring reliable and accessible testing for diverse clinical applications.